Illicit drug supply in France in 2021

In 2021, the quantities seized by the police, the gendarmerie and customs have reached unprecedented levels for marijuana, cocaine and even heroin. In addition, the levels of substances circulating the country from cannabis resin and heroin to cocaine and MDMA/ecstasy are high, while retail prices are fairly stable or down slightly.

Deal-stupéfiants-drogues
See the notice on the bibliographic catalog

The objective of this first report on the supply of illicit drugs in France in 2021 is to produce a contextualised inventory based on the main indicators and data available, updated each year.

The illicit drug market in France is structured, particularly in terms of volume, around four main substances, namely cannabis, cocaine, heroin, and MDMA/ecstasy. For the past twenty years, it has been affected by a dynamic and increasingly diversified international supply of illicit drugs. 2021 was marked by record cocaine production in Colombia, as well as very high levels of opium and heroin production in Afghanistan and synthetic drugs in the European Union.

Publication type
Briefing papers
Publication date
Language
Français
Author(s)
GANDILHON
Michel
Edited by
OFDT
Number of pages
13
ISBN
979-10-92728-63-7
Products & addictions
Cannabis
Cocaine and crack
Heroin and opioids
MDMA/ecstasy and amphetamine
Themes
Supply and markets
Territories
France

See also

30 years of penal response to driving under the influence of alcohol or drugs
  • Alcohol
  • Cannabis
  • Cocaine and crack
  • Heroin and opioids
  • MDMA/ecstasy and amphetamine
Tendances
161
2024
OFDT
8 pages
Drug use in adolescence: trends reported in 2022
  • Alcohol
  • Cannabis
  • e-Cigarette
  • Cocaine and crack
  • GHB and solvents
  • Heroin and opioids
  • Ketamine
  • LSD and mushrooms
  • MDMA/ecstasy and amphetamine
  • Poppers
  • Nitrous oxide
  • Tobacco
Briefing papers
2024
OFDT
17 pages
Psychoactive substances, users and markets in France in 2022
  • Benzodiazepines and gabapentinoids
  • Cannabis
  • Cocaine and crack
  • Heroin and opioids
  • Ketamine
  • LSD and mushrooms
  • MDMA/ecstasy and amphetamine
  • New Psychoactive Substances
  • Poppers
  • Nitrous oxide
  • Others
Tendances
160
2023
OFDT
8 pages

Latest publications Briefing papers

All publications Briefing papers
Drug use in adolescence: trends reported in 2022
  • Alcohol
  • Cannabis
  • e-Cigarette
  • Cocaine and crack
  • GHB and solvents
  • Heroin and opioids
  • Ketamine
  • LSD and mushrooms
  • MDMA/ecstasy and amphetamine
  • Poppers
  • Nitrous oxide
  • Tobacco
  • Users
  • France

Psychoactive substance use among middle school and high school students: results of the EnCLASS 2022 survey.

Briefing papers
2024
OFDT
17 pages
Alcohol consumption and its consequences in France in 2022
  • Alcohol
  • Supply and markets
  • Treatment
  • Users
  • France

This report from the French Monitoring Centre for Drugs and Drug Addiction (OFDT) provides an overview of the supply, uses, and the social and health consequences of alcohol consumption in France in 2022

Briefing papers
2023
OFDT
9 pages
The social cost of drugs: an estimation in France in 2019
  • Alcohol
  • Cocaine and crack
  • Heroin and opioids
  • Tobacco
  • Public policy and healthcare provision
  • France

This report presents a new estimate of the social cost of drugs in France in 2019, following a previous calculation in 2010

Briefing papers
2023
OFDT
15 pages
Opioid substitution treatment in France: 2023 report
  • Heroin and opioids
  • Treatment
  • France

The aim of this report is to present updated data on opioid substitution treatment in France. It is based on the latest available data, the year of which may vary from 2019 to 2022 depending on the source and the treatment period.

Briefing papers
2023
OFDT
14 pages